Oxford Medical Simulation (OMS), based in London, has announced £5 million in growth financing from Salica Investments.

Funding Objectives

The funds will be used to:

  • Expand OMS's presence in the US market.
  • Accelerate the development of AI-driven products, with a focus on virtual reality (VR) simulations for medical training. These simulations allow clinicians to practice emergencies and difficult conversations in a safe virtual environment.

Background

OMS operates in the healthtech sector, a rapidly growing area that sees the application of innovative technologies to improve medical training and practice. Virtual reality offers an immersive and interactive learning environment, ideal for simulating complex and rare scenarios that doctors may face in their careers. Integration with artificial intelligence promises to further personalize the learning experience, adapting simulations to the specific needs of each professional.